Top 3 Marijuana Stocks to Watch in June 2026
The cannabis sector continues evolving as operators focus on profitability, cash flow, and market expansion. Federal cannabis reform discussions remain a major catalyst. Meanwhile, leading multistate operators continue strengthening their positions across key U.S. markets. Investors searching for cannabis exposure may want to focus on companies with strong retail footprints and improving financial performance.
Three companies stand out heading into June 2026. Trulieve Cannabis, Curaleaf Holdings, and Green Thumb Industries have established national brands and significant operating scale. Additionally, all three companies recently reported encouraging financial results. Their ability to generate revenue and maintain profitability could make them attractive stocks to watch during the coming months.
[Read More] 3 Cannabis Stocks That Could Outperform in June 2026
Top 3 Marijuana Stocks to Watch in June 2026
- Trulieve Cannabis (OTC: TCNNF)
- Curaleaf Holdings (OTC: CURLF)
- Green Thumb Industries (OTC: GTBIF)
Trulieve Cannabis (OTC: TCNNF)
Trulieve Cannabis remains one of the largest cannabis operators in the United States. The company built its reputation through its dominant position in Florida. Florida remains Trulieve’s largest market and serves as the foundation of its retail strategy. The company has steadily expanded into other states while maintaining a strong presence in the Southeast. As of May 2026, Trulieve operated approximately 240 dispensaries nationwide. Its retail network reaches customers across several key cannabis markets. Additionally, the company operates extensive cultivation and processing facilities throughout the country.
Trulieve focuses heavily on vertically integrated operations. This approach helps control product quality and improve margins. Furthermore, the company has developed several popular in-house brands. These brands generate customer loyalty and repeat purchases. Trulieve continues investing in retail growth while improving operational efficiency. The company also benefits from strong brand recognition among medical cannabis patients. As cannabis regulations evolve, Trulieve remains positioned to capitalize on future opportunities. Its large footprint and established infrastructure provide a competitive advantage. Therefore, many investors consider the company a leading cannabis stock for long-term growth.
Latest Financials
Financially, Trulieve delivered a strong start to 2026. First-quarter revenue reached approximately $287 million. Gross margin came in at 59%, demonstrating operational efficiency. The company also reported positive net income of approximately $2 million. Adjusted EBITDA totaled roughly $100 million. Additionally, operating cash flow reached approximately $56 million. Free cash flow exceeded $42 million during the quarter. These results reflected management’s focus on profitability and cost discipline. Trulieve also ended the quarter with a substantial cash position. Revenue remained primarily driven by retail sales. Furthermore, the company benefited from improving industry conditions and regulatory developments. Full-year 2025 revenue reached approximately $1.2 billion. The company also generated record operating cash flow during 2025. Strong cash generation provides flexibility for future expansion. Therefore, Trulieve appears well-positioned heading into the second half of 2026. Investors will continue monitoring revenue growth and margin performance closely.
[Read More] Best Marijuana Stocks to Watch for Potential Upside in June 2026
Curaleaf Holdings (OTC: CURLF)
Curaleaf remains one of the largest cannabis companies in North America. The company operates a broad footprint spanning numerous states and international markets. Its strongest presence is concentrated in major cannabis markets, including Florida, New York, and several northeastern states. Curaleaf has focused on building a nationally recognized cannabis brand. The company serves both medical and adult-use consumers. Additionally, Curaleaf offers a diverse portfolio of cannabis products. These products include flower, concentrates, edibles, and wellness offerings.
The company operates approximately 150 dispensaries across the United States. Its retail presence provides access to millions of potential consumers. Furthermore, Curaleaf continues expanding product distribution beyond company-owned stores. This strategy increases market penetration while supporting brand growth. Management has also pursued international opportunities. These efforts provide additional long-term growth potential. Curaleaf’s large-scale operations create purchasing advantages and operational efficiencies. As a result, the company remains one of the most closely watched cannabis operators. Investors often view Curaleaf as a bellwether for the broader cannabis industry. Its national reach and diversified operations help reduce reliance on any single market.
Latest Financials
Curaleaf reported encouraging first-quarter 2026 financial results. Net revenue reached approximately $324 million. This represented year-over-year growth of roughly 6%. Gross profit totaled approximately $157 million. Gross margin remained strong at approximately 49%. Additionally, the company reported net income of approximately $70 million. These results highlighted improved operational execution and financial discipline. Curaleaf also continued expanding its international business. International revenue contributed meaningfully to quarterly performance. Furthermore, management completed strategic initiatives that strengthened the company’s long-term outlook. Full-year 2025 results also demonstrated steady progress. Fourth-quarter revenue reached approximately $333 million. Operating cash flow remained positive throughout the year. The company continues emphasizing profitability and cash generation. This focus differentiates Curaleaf from many smaller cannabis operators. Investors will be watching future quarters for continued margin stability and revenue growth. If management maintains current momentum, Curaleaf could remain a leading cannabis stock throughout 2026.
[Read More] 3 Canadian Marijuana Stocks That Could Help You Make Money
Green Thumb Industries (OTC: GTBIF)
Green Thumb Industries has established itself as one of the most respected operators in the cannabis industry. The company operates under several well-known consumer brands. Additionally, Green Thumb owns the RISE dispensary chain. Illinois remains one of the company’s most important markets. However, Green Thumb operates in numerous states. Its retail network continues expanding in both medical and adult-use markets. The company operates approximately 100 dispensaries nationwide. Green Thumb has built a reputation for disciplined growth and operational excellence. Furthermore, management consistently emphasizes profitability rather than rapid expansion. This strategy has attracted many long-term investors.
The company’s product portfolio includes premium flower, edibles, concentrates, and wellness products. Green Thumb also benefits from strong consumer brand recognition. Its vertically integrated model helps support consistent product quality. Additionally, the company continues investing in cultivation and manufacturing capabilities. These investments strengthen its competitive position. As more states expand cannabis programs, Green Thumb remains well-positioned for growth. Its balanced approach to expansion and profitability makes it one of the industry’s strongest operators. Therefore, GTBIF remains a stock that many cannabis investors continue to monitor closely.
Latest Financials
Green Thumb delivered another solid quarter in early 2026. First-quarter revenue reached approximately $300 million. This represented year-over-year growth of roughly 7.4%. The company also reported net income of approximately $15 million. Normalized EBITDA totaled approximately $94 million. Furthermore, operating cash flow reached approximately $76 million. Green Thumb ended the quarter with more than $340 million in cash. This strong balance sheet supports future growth opportunities. Management also repurchased shares during the quarter. Share repurchases demonstrate confidence in the company’s outlook. Additionally, Green Thumb expanded its credit facility. These actions improve financial flexibility. Full-year 2025 revenue reached approximately $1.2 billion. Revenue growth was supported by the expansion of retail operations and new market opportunities. Despite industry pricing pressure, Green Thumb maintained profitability. This performance highlights the strength of its operating model. Investors will continue watching revenue growth, cash generation, and margin trends throughout 2026. Strong financial execution could help GTBIF remain a leader in the cannabis sector.
MAPH Enterprises, LLC | (305) 414-0128 | 1501 Venera Ave, Coral Gables, FL 33146 | new@marijuanastocks.com
